PD 151746

Also Known As:

3-(5-fluoro-3-indolyl)-2-mercapto-(Z)-2-propenoic acid; PD-151746; PD151746

Networked: 5 relevant articles (0 outcomes, 0 trials/studies)

1.	Stroke (Strokes) 01/01/2018 - "Calpain 1-specific inhibitor PD151746 further increased p-STAT3 expression and augmented the promoting effects of EE on post-stroke SVZ neural precursor cells (NPCs) proliferation and functional recovery. "
2.	Sleep Deprivation 01/01/2022 - "Moreover, sleep deprivation induced a lower pain threshold than the rest control, which was partly reversed by microinjection of GsMTx4 or PD151746. "
3.	Psoriasis (Pustulosis Palmaris et Plantaris) 01/01/2017 - "At last, PD 151746 (calpain-1 inhibitor) treatment decreased epidermal thickness in imquimod-induced psoriasis model. "
4.	Infections 01/01/2022 - "The selective inhibition of calpain-1 using PD151746 protected cardiomyocytes in vitro from CVB3 infection by downregulating NLRP3 inflammasome and, thus, preserved cell viability. "
5.	Hepatocellular Carcinoma (Hepatoma) 04/01/2007 - "We investigated the effects of the calpains 1 and 2 inhibitor PD151746 on insulin signaling and insulin action in human hepatoma G2 cells (HepG2). "